{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2,4-dinitrochlorobenzene", "Dioscorea quinqueloba", "atopic dermatitis", "gracillin", "interleukin 4", "skin barrier recovery"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30200442", "DateCompleted": {"Year": "2019", "Month": "01", "Day": "10"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "09", "Day": "01"}], "Language": ["eng"], "ELocationID": ["1205", "10.3390/nu10091205"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "10", "Issue": "9", "PubDate": {"Year": "2018", "Month": "Sep", "Day": "01"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Anti-Atopic Properties of Gracillin Isolated from <i>Dioscorea quinqueloba</i> on 2,4-Dinitrochlorobenzene-Induced Skin Lesions in Mice.", "Abstract": {"AbstractText": ["Naturally occurring saponins have been reported to have anti-inflammatory and immunomodulatory effects. However, the effects of gracillin, a main saponin component of <i>Dioscorea quinqueloba</i> (<i>D. quinqueloba</i>), on atopic dermatitis (AD), have not been previously studied. The aim of this study was to determine whether gracillin isolated from <i>D. quinqueloba</i> has an anti-AD effect on 2,4-dinitrochlorobenzene (DNCB)-induced AD-like skin lesions in SKH-1 hairless mice. Topical co-treatment of gracillin and DNCB for two weeks markedly reduced symptoms typical of AD (redness, itching, swelling and skin lichenification), decreased transepidermal water loss (TEWL) and increased skin hydration. In addition, gracillin strongly inhibited PI-induced IL-4 expression in RBL-2H3 cells and in the skins of AD mice. Our results suggest gracillin is a potential candidate for the prevention and treatment of AD and other inflammatory skin disorders."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea. jhjegal@pusan.ac.kr."}], "LastName": "Jegal", "ForeName": "Jonghwan", "Initials": "J"}, {"Identifier": ["0000-0001-5528-6446"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Korea. parknojune@kist.re.kr."}], "LastName": "Park", "ForeName": "No-June", "Initials": "NJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea. dtc98103@pusan.ac.kr."}], "LastName": "Jo", "ForeName": "Beom-Geun", "Initials": "BG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Korea. 115044@kist.re.kr."}], "LastName": "Bong", "ForeName": "Sim-Kyu", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Korea. 116524@kist.re.kr."}], "LastName": "Jegal", "ForeName": "Hyun", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, Korea. mhyang@pusan.ac.kr."}], "LastName": "Yang", "ForeName": "Min Hye", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Korea. snkim@kist.re.kr."}], "LastName": "Kim", "ForeName": "Su-Nam", "Initials": "SN"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Dermatologic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Dinitrochlorobenzene"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Spirostans"}, {"RegistryNumber": "19083-00-2", "NameOfSubstance": "gracillin"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "37341-29-0", "NameOfSubstance": "Immunoglobulin E"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["chemically induced", "metabolism", "pathology", "prevention & control"], "DescriptorName": "Dermatitis, Atopic"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Dermatologic Agents"}, {"QualifierName": [], "DescriptorName": "Dinitrochlorobenzene"}, {"QualifierName": ["chemistry"], "DescriptorName": "Dioscorea"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin E"}, {"QualifierName": ["blood"], "DescriptorName": "Interleukin-4"}, {"QualifierName": [], "DescriptorName": "Mice, Hairless"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Skin"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Spirostans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Water Loss, Insensible"}], "CoiStatement": "The authors have no conflict of interest to declare."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New insights into atopic dermatitis. J. Clin. Investig. 2004;113:651\u2013657. doi: 10.1172/JCI21060.", "ArticleIdList": ["10.1172/JCI21060", "PMC351324", "14991059"]}, {"Citation": "Guttman-Yassky E., Nograles K.E., Krueger J.G. Contrasting pathogenesis of atopic dermatitis and psoriasis\u2014Part i: Clinical and pathologic concepts. J. Allergy Clin. Immunol. 2011;127:1110\u20131118. doi: 10.1016/j.jaci.2011.01.053.", "ArticleIdList": ["10.1016/j.jaci.2011.01.053", "21388665"]}, {"Citation": "Tha\u00e7i D., Simpson E.L., Beck L.A., Bieber T., Blauvelt A., Papp K., Soong W., Worm M., Szepietowski J.C., Sofen H., et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: A randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet. 2016;387:40\u201352. doi: 10.1016/S0140-6736(15)00388-8.", "ArticleIdList": ["10.1016/S0140-6736(15)00388-8", "26454361"]}, {"Citation": "Cork M.J., Robinson D.A., Vasilopoulos Y., Ferguson A., Moustafa M., MacGowan A., Duff G.W., Ward S.J., Tazi-Ahnini R. New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene-environment interactions. J. Allergy Clin. Immunol. 2006;118:3\u201321. doi: 10.1016/j.jaci.2006.04.042.", "ArticleIdList": ["10.1016/j.jaci.2006.04.042", "16815133"]}, {"Citation": "Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J. Dermatol. Sci. 2010;58:1\u20137. doi: 10.1016/j.jdermsci.2010.02.008.", "ArticleIdList": ["10.1016/j.jdermsci.2010.02.008", "20207111"]}, {"Citation": "Renz H., Jujo K., Bradley K.L., Domenico J., Gelfand E.W., Leung D.Y. Enhanced il-4 production and il-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J. Invest. Dermatol. 1992;99:403\u2013408. doi: 10.1111/1523-1747.ep12616114.", "ArticleIdList": ["10.1111/1523-1747.ep12616114", "1401997"]}, {"Citation": "Simpson E.L. Atopic dermatitis: A review of topical treatment options. Curr. Med. Res. Opin. 2010;26:633\u2013640. doi: 10.1185/03007990903512156.", "ArticleIdList": ["10.1185/03007990903512156", "20070141"]}, {"Citation": "Sidana J., Singh B., Sharma O.P. Saponins of agave: Chemistry and bioactivity. Phytochemistry. 2016;130:22\u201346. doi: 10.1016/j.phytochem.2016.06.010.", "ArticleIdList": ["10.1016/j.phytochem.2016.06.010", "27374482"]}, {"Citation": "G\u00fc\u00e7l\u00fc-\u00dcst\u00fcnda\u011f \u00d6., Mazza G. Saponins: Properties, applications and processing. Crit. Rev. Food Sci. Nutr. 2007;47:231\u2013258. doi: 10.1080/10408390600698197.", "ArticleIdList": ["10.1080/10408390600698197", "17453922"]}, {"Citation": "Lacaille-Dubois M.A., Wagner H. A review of the biological and pharmacological activities of saponins. Phytomedicine. 1996;2:363\u2013386. doi: 10.1016/S0944-7113(96)80081-X.", "ArticleIdList": ["10.1016/S0944-7113(96)80081-X", "23194774"]}, {"Citation": "Sautour M., Mitaine-Offer A.-C., Lacaille-Dubois M.-A. The dioscorea genus: A review of bioactive steroid saponins. J. Nat. Med. 2007;61:91\u2013101. doi: 10.1007/s11418-006-0126-3.", "ArticleIdList": ["10.1007/s11418-006-0126-3"]}, {"Citation": "Wagner H., Wiesenauer M. Phytotherapie Gustav Fischer Verlag. Stuttgart; Jena, New York, NY, USA: 1995."}, {"Citation": "Bae E.-A., Trinh H.T., Yoon H.-K., Kim D.-H. Compound k, a metabolite of ginsenoside rb1, inhibits passive cutaneous anaphylaxis reaction in mice. J. Ginseng Res. 2009;33:93\u201398."}, {"Citation": "Choi J.H., Jin S.W., Han E.H., Park B.H., Kim H.G., Khanal T., Hwang Y.P., Do M.T., Lee H.-S., Chung Y.C. Platycodon grandiflorum root-derived saponins attenuate atopic dermatitis-like skin lesions via suppression of nf-\u03bab and stat1 and activation of nrf2/are-mediated heme oxygenase-1. Phytomedicine. 2014;21:1053\u20131061. doi: 10.1016/j.phymed.2014.04.011.", "ArticleIdList": ["10.1016/j.phymed.2014.04.011", "24854572"]}, {"Citation": "Karnick C.R. Dioscorea (yams)\u2014The food of the slaves, with potentials for newer drugs: A review. Q. J. Crude Drug Res. 1969;9:1372\u20131391. doi: 10.3109/13880206909066280.", "ArticleIdList": ["10.3109/13880206909066280"]}, {"Citation": "Kwon C.-S., Sohn H.Y., Kim S.H., Kim J.H., Son K.H., Lee J.S., Lim J.K., Kim J.-S. Anti-obesity effect of dioscorea nipponica makino with lipase-inhibitory activity in rodents. Biosci. Biotechnol. Biochem. 2003;67:1451\u20131456. doi: 10.1271/bbb.67.1451.", "ArticleIdList": ["10.1271/bbb.67.1451", "12913286"]}, {"Citation": "Kyung-Mi K., Moon-Kyung K., Jin-Sook K., Gi-Chang K., Song-Yi C. Physicochemical composition and antioxidant activities of Korean dioscorea species. J. East Asian Soc. Diet. Life. 2015;25:880\u2013886."}, {"Citation": "Jegal J., Park N.J., Bong S.K., Jegal H., Kim S.N., Yang M.H. Dioscorea quinqueloba ameliorates oxazolone- and 2,4-dinitrochlorobenzene-induced atopic dermatitis symptoms in murine models. Nutrients. 2017;9:1324. doi: 10.3390/nu9121324.", "ArticleIdList": ["10.3390/nu9121324", "PMC5748774", "29206209"]}, {"Citation": "Liao B.-C., Hou R.C.-W., Wang J.-S., Jeng K.-C.G. Enhancement of the release of inflammatory mediators by substance p in rat basophilic leukemia rbl-2h3 cells. J. Biomed. Sci. 2006;13:613\u2013619. doi: 10.1007/s11373-006-9099-1.", "ArticleIdList": ["10.1007/s11373-006-9099-1", "16847722"]}, {"Citation": "Boguniewicz M., Leung D.Y.M. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol. Rev. 2011;242:233\u2013246. doi: 10.1111/j.1600-065X.2011.01027.x.", "ArticleIdList": ["10.1111/j.1600-065X.2011.01027.x", "PMC3122139", "21682749"]}, {"Citation": "Amirkia V., Heinrich M. Natural products and drug discovery: A survey of stakeholders in industry and academia. Front. Pharmacol. 2015;6:273. doi: 10.3389/fphar.2015.00237.", "ArticleIdList": ["10.3389/fphar.2015.00237", "PMC4620409", "26578954"]}, {"Citation": "Mats L., Ulla P., Per L., Carl M., Edvard S.C.I., Lennart H., Eva S. Interleukin 4 induces synthesis of ige and igg4 in human b cells. Eur. J. Immunol. 1989;19:1311\u20131315.", "ArticleIdList": ["2788092"]}, {"Citation": "Tang M., Kemp A., Varigos G. Il-4 and interferon-gamma production in children with atopic disease. Clin. Exp. Immunol. 1993;92:120\u2013124. doi: 10.1111/j.1365-2249.1993.tb05957.x.", "ArticleIdList": ["10.1111/j.1365-2249.1993.tb05957.x", "PMC1554873", "8467557"]}, {"Citation": "Atherton D.J. Topical corticosteroids in atopic dermatitis. BMJ. 2003;327:942\u2013943. doi: 10.1136/bmj.327.7421.942.", "ArticleIdList": ["10.1136/bmj.327.7421.942", "PMC259155", "14576221"]}, {"Citation": "Charman C.R., Morris A.D., Williams H.C. Topical corticosteroid phobia in patients with atopic eczema. Br. J. Dermatol. 2000;142:931\u2013936. doi: 10.1046/j.1365-2133.2000.03473.x.", "ArticleIdList": ["10.1046/j.1365-2133.2000.03473.x", "10809850"]}, {"Citation": "Nghiem P., Pearson G., Langley R.G. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J. Am. Acad. Dermatol. 2002;46:228\u2013241. doi: 10.1067/mjd.2002.120942.", "ArticleIdList": ["10.1067/mjd.2002.120942", "11807435"]}, {"Citation": "Williams H. New treatments for atopic dermatitis: Good news, but when and how to use tacrolimus and pimecrolimus is a muddle. BMJ. 2002;324:1533\u20131534. doi: 10.1136/bmj.324.7353.1533.", "ArticleIdList": ["10.1136/bmj.324.7353.1533", "PMC1123485", "12089073"]}, {"Citation": "Werner Y., Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta. Derm. Venereol. 1985;65:102\u2013105.", "ArticleIdList": ["2408409"]}, {"Citation": "Sator P.-G., Schmidt J.B., H\u00f6nigsmann H. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J. Am. Acad. Dermatol. 2003;48:352\u2013358. doi: 10.1067/mjd.2003.105.", "ArticleIdList": ["10.1067/mjd.2003.105", "12637914"]}, {"Citation": "Marsella R., Olivry T., Carlotti D.N., International Task Force on Canine Atopic Dermatitis Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Vet. Dermatol. 2011;22:239\u2013248. doi: 10.1111/j.1365-3164.2011.00967.x.", "ArticleIdList": ["10.1111/j.1365-3164.2011.00967.x", "21414049"]}, {"Citation": "Lod\u00e9n M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am. J. Clin. Dermatol. 2003;4:771\u2013788. doi: 10.2165/00128071-200304110-00005.", "ArticleIdList": ["10.2165/00128071-200304110-00005", "14572299"]}, {"Citation": "Loden M., Andersson A., Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (canoderm (r)) Br. J. Dermatol. 1999;140:264\u2013267. doi: 10.1046/j.1365-2133.1999.02660.x.", "ArticleIdList": ["10.1046/j.1365-2133.1999.02660.x", "10233220"]}, {"Citation": "Simpson E.L., Chalmers J.R., Hanifin J.M., Thomas K.S., Cork M.J., McLean W.I., Brown S.J., Chen Z., Chen Y., Williams H.C. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J. Allergy Clin. Immunol. 2014;134:818\u2013823. doi: 10.1016/j.jaci.2014.08.005.", "ArticleIdList": ["10.1016/j.jaci.2014.08.005", "PMC4180007", "25282563"]}]}], "History": [{"Year": "2018", "Month": "7", "Day": "27"}, {"Year": "2018", "Month": "8", "Day": "23"}, {"Year": "2018", "Month": "8", "Day": "29"}, {"Year": "2018", "Month": "9", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["30200442", "PMC6164938", "10.3390/nu10091205", "nu10091205"]}}]}